Literature DB >> 20484116

TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.

Qisheng Peng1, Shikha Malhotra, James A Torchia, William G Kerr, K Mark Coggeshall, Mary Beth Humphrey.   

Abstract

The activation and fusion of macrophages and of osteoclasts require the adaptor molecule DNAX-activating protein of 12 kD (DAP12), which contains immunoreceptor tyrosine-based activation motifs (ITAMs). TREM2 (triggering receptor expressed on myeloid cells-2) is the main DAP12-associated receptor in osteoclasts and, similar to DAP12 deficiency, loss of TREM2 in humans leads to Nasu-Hakola disease, which is characterized by bone cysts and dementia. Furthermore, in vitro experiments have shown that deficiency in DAP12 or TREM2 leads to impaired osteoclast development and the formation of mononuclear osteoclasts. Here, we demonstrate that the ligation of TREM2 activated phosphatidylinositol 3-kinase (PI3K), extracellular signal-regulated kinase 1 (ERK1) and ERK2, and the guanine nucleotide exchange factor Vav3; induced the mobilization of intracellular calcium (Ca(2+)) and the reorganization of actin; and prevented apoptosis. The signaling adaptor molecule DAP10 played a key role in the TREM2- and DAP12-dependent recruitment of PI3K to the signaling complex. Src homology 2 (SH2) domain-containing inositol phosphatase-1 (SHIP1) inhibited TREM2- and DAP12-induced signaling by binding to DAP12 in an SH2 domain-dependent manner and preventing the recruitment of PI3K to DAP12. These results demonstrate a previously uncharacterized interaction of SHIP1 with DAP12 that functionally limits TREM2- and DAP12-dependent signaling and identify a mechanism through which SHIP1 regulates key ITAM-containing receptors by directly blocking the binding and activation of PI3K.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484116      PMCID: PMC2900152          DOI: 10.1126/scisignal.2000500

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  51 in total

1.  Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.

Authors:  Kun Jiang; Bin Zhong; Danielle L Gilvary; Brian C Corliss; Eric Vivier; Elizabeth Hong-Geller; Sheng Wei; Julie Y Djeu
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

2.  Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production.

Authors:  David G T Hesslein; Rayna Takaki; Michelle L Hermiston; Arthur Weiss; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

3.  DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk.

Authors:  Wei Zou; Jennifer L Reeve; Yuli Liu; Steven L Teitelbaum; F Patrick Ross
Journal:  Mol Cell       Date:  2008-08-08       Impact factor: 17.970

4.  SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling.

Authors:  L O Beitz; D A Fruman; T Kurosaki; L C Cantley; A M Scharenberg
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

5.  SHIP is required for a functional hematopoietic stem cell niche.

Authors:  Amy L Hazen; Michelle J Smith; Caroline Desponts; Oliver Winter; Katrin Moser; William G Kerr
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

6.  DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivo.

Authors:  Ilaria Tassi; Gaelle Le Friec; Susan Gilfillan; Toshiyuki Takai; Wayne M Yokoyama; Marco Colonna
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

7.  Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12.

Authors:  Masanori Inui; Yuki Kikuchi; Naoko Aoki; Shota Endo; Tsutomu Maeda; Akiko Sugahara-Tobinai; Shion Fujimura; Akira Nakamura; Atsushi Kumanogoh; Marco Colonna; Toshiyuki Takai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-27       Impact factor: 11.205

8.  Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRgamma.

Authors:  Ching-Liang Chu; Yen-Ling Yu; Kuan-Yin Shen; Clifford A Lowell; Lewis L Lanier; Jessica A Hamerman
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

9.  RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro.

Authors:  Karen A Sutherland; Helena L Rogers; Denise Tosh; Michael J Rogers
Journal:  Arthritis Res Ther       Date:  2009-04-30       Impact factor: 5.156

10.  TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria.

Authors:  Elsa-Noah N'Diaye; Catherine S Branda; Steven S Branda; Lisette Nevarez; Marco Colonna; Clifford Lowell; Jessica A Hamerman; William E Seaman
Journal:  J Cell Biol       Date:  2009-01-26       Impact factor: 10.539

View more
  129 in total

1.  Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.

Authors:  Shannon K O'Neill; Andrew Getahun; Stephen B Gauld; Kevin T Merrell; Idan Tamir; Mia J Smith; Joseph M Dal Porto; Quan-Zhen Li; John C Cambier
Journal:  Immunity       Date:  2011-11-09       Impact factor: 31.745

2.  TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells.

Authors:  Hiroaki Ito; Jessica A Hamerman
Journal:  Eur J Immunol       Date:  2011-12-12       Impact factor: 5.532

3.  Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice.

Authors:  Ricky Cheung; Fran Shen; Joseph H Phillips; Mandy J McGeachy; Daniel J Cua; Paul G Heyworth; Robert H Pierce
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

4.  Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8.

Authors:  Sharmistha Bhattacharyya; Nagaraja S Balakathiresan; Clifton Dalgard; Usha Gutti; David Armistead; Cathy Jozwik; Meera Srivastava; Harvey B Pollard; Roopa Biswas
Journal:  J Biol Chem       Date:  2011-01-31       Impact factor: 5.157

5.  TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis.

Authors:  Karel Otero; Masahiro Shinohara; Haibo Zhao; Marina Cella; Susan Gilfillan; Angela Colucci; Roberta Faccio; F Patrick Ross; Steve L Teitelbaum; Hiroshi Takayanagi; Marco Colonna
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

6.  Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP.

Authors:  Michelle M Collazo; Kim H T Paraiso; Mi-Young Park; Amy L Hazen; William G Kerr
Journal:  Eur J Immunol       Date:  2012-07       Impact factor: 5.532

7.  SHIP1 regulates MSC numbers and their osteolineage commitment by limiting induction of the PI3K/Akt/β-catenin/Id2 axis.

Authors:  Sonia Iyer; Dennis R Viernes; John D Chisholm; Bryan S Margulies; William G Kerr
Journal:  Stem Cells Dev       Date:  2014-07-03       Impact factor: 3.272

Review 8.  TREM2 variants: new keys to decipher Alzheimer disease pathogenesis.

Authors:  Marco Colonna; Yaming Wang
Journal:  Nat Rev Neurosci       Date:  2016-02-25       Impact factor: 34.870

Review 9.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

10.  TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy.

Authors:  Peng Yuan; Carlo Condello; C Dirk Keene; Yaming Wang; Thomas D Bird; Steven M Paul; Wenjie Luo; Marco Colonna; David Baddeley; Jaime Grutzendler
Journal:  Neuron       Date:  2016-05-18       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.